BRAF and melanoma: In BRAF-mutated melanoma, the constitutive activation of BRAF kinase triggers a metabolic rewiring which involves a cascade of consequences, including HIF-1 activation [109] which is normally induced in response to low oxygen levels and increased expression of glucose transporters and glycolytic enzymes [108] (e.g., SLC7A11).